Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3367)
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
80,258
Price
$6.44
Total Value
$516.61K
Shares Held After
270,931
% of Holdings
22.9%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
26,837
Price
$6.44
Total Value
$172.75K
Shares Held After
108,984
% of Holdings
19.8%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
32,410
Price
$185.60
Total Value
$6.02M
Shares Held After
7,229
% of Holdings
81.8%
ABEONA THERAPEUTICS INC. (ABEO)
Crombez Eric — Director
Shares
16,284
Price
$5.09
Total Value
$82.90K
Shares Held After
63,456
% of Holdings
20.4%
ABEONA THERAPEUTICS INC. (ABEO)
Wuchterl Donald A. — Director
Shares
14,814
Price
$5.09
Total Value
$75.41K
Shares Held After
167,935
% of Holdings
8.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$7.45
Total Value
$124.15K
Shares Held After
1,243,174
% of Holdings
1.3%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,349
Price
$7.76
Total Value
$80.31K
Shares Held After
98,477
% of Holdings
9.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
3,800
Price
$4.04
Total Value
$15.35K
Shares Held After
555,559
% of Holdings
0.7%
ZEVRA THERAPEUTICS, INC. (ZVRA)
McFarlane Neil F. — Director
Shares
91,000
Price
$9.38
Total Value
$853.43K
Shares Held After
364,350
% of Holdings
20.0%
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
18,065
Price
$5.09
Total Value
$91.96K
Shares Held After
173,614
% of Holdings
9.4%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
2,000
Price
$5.09
Total Value
$10.18K
Shares Held After
84,065
% of Holdings
2.3%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
886
Price
$62.10
Total Value
$55.02K
Shares Held After
50,440
% of Holdings
1.7%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,135
Price
$21.39
Total Value
$45.67K
Shares Held After
639,140
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,136
Price
$21.39
Total Value
$45.69K
Shares Held After
639,141
% of Holdings
0.3%
Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J — Chief Legal Officer
Shares
1,010
Price
$25.01
Total Value
$25.26K
Shares Held After
104,376
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,296
Price
$82.96
Total Value
$439.36K
Shares Held After
45,413
% of Holdings
10.4%
IONIS PHARMACEUTICALS INC (IONS)
Birchler Brian — EVP, Corp and Development Ops
Shares
6,179
Price
$83.03
Total Value
$513.05K
Shares Held After
66,247
% of Holdings
8.5%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
6,179
Price
$83.53
Total Value
$516.15K
Shares Held After
71,983
% of Holdings
7.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
6,988
Price
$83.24
Total Value
$581.70K
Shares Held After
132,881
% of Holdings
5.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
5,885
Price
$82.95
Total Value
$488.14K
Shares Held After
100,293
% of Holdings
5.5%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
6,179
Price
$83.45
Total Value
$515.63K
Shares Held After
69,702
% of Holdings
8.1%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,179
Price
$82.93
Total Value
$512.45K
Shares Held After
47,747
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
62,970
Price
$82.72
Total Value
$5.21M
Shares Held After
283,927
% of Holdings
18.2%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$41.09
Total Value
$821.81K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,686
Price
$4.13
Total Value
$23.48K
Shares Held After
559,359
% of Holdings
1.0%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Quartel Adrian W — Chief Medical Officer
Shares
4,533
Price
$8.83
Total Value
$40.04K
Shares Held After
9,723
% of Holdings
31.8%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Schafer Joshua — CCO
Shares
3,375
Price
$8.83
Total Value
$29.80K
Shares Held After
37,444
% of Holdings
8.3%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
4,080
Price
$8.83
Total Value
$36.01K
Shares Held After
49,919
% of Holdings
7.6%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Sangiovanni Timothy J. — SVP, Finance & Corp Controller
Shares
1,750
Price
$8.82
Total Value
$15.44K
Shares Held After
20,924
% of Holdings
7.7%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
2,906
Price
$29.00
Total Value
$84.27K
Shares Held After
986,667
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
22,094
Price
$28.27
Total Value
$624.67K
Shares Held After
989,573
% of Holdings
2.2%
Aprea Therapeutics, Inc. (APRE)
Hamill John P. — SrVP/CFO/Prin Fin & Acct Ofcr
Shares
5,700
Price
$0.89
Total Value
$5.07K
Shares Held After
33,433
% of Holdings
17.0%
Aprea Therapeutics, Inc. (APRE)
Gilad Oren — Director
Shares
28,100
Price
$0.89
Total Value
$25.01K
Shares Held After
373,720
% of Holdings
7.5%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
6,612
Price
$18.11
Total Value
$119.74K
Shares Held After
365,273
% of Holdings
1.8%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
98
Price
$17.37
Total Value
$1.70K
Shares Held After
83,672
% of Holdings
0.1%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
4,797
Price
$16.58
Total Value
$79.55K
Shares Held After
83,770
% of Holdings
5.4%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
73
Price
$17.37
Total Value
$1.27K
Shares Held After
45,427
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
3,588
Price
$16.58
Total Value
$59.50K
Shares Held After
45,500
% of Holdings
7.3%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
88
Price
$17.37
Total Value
$1.53K
Shares Held After
57,010
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
4,333
Price
$16.58
Total Value
$71.85K
Shares Held After
57,098
% of Holdings
7.1%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
15,284
Price
$4.32
Total Value
$66.03K
Shares Held After
565,045
% of Holdings
2.6%
DBV Technologies S.A. (DBVT)
Mohideen Pharis — Chief Medical Officer
Shares
534
Price
$4.86
Total Value
$2.60K
Shares Held After
144,995
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
63
Price
$103.39
Total Value
$6.51K
Shares Held After
58,117
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,819
Price
$102.67
Total Value
$186.76K
Shares Held After
58,180
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,429
Price
$101.80
Total Value
$349.07K
Shares Held After
59,999
% of Holdings
5.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
189
Price
$100.95
Total Value
$19.08K
Shares Held After
63,428
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
8,667
Price
$29.74
Total Value
$257.78K
Shares Held After
986,667
% of Holdings
0.9%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
16,333
Price
$29.19
Total Value
$476.80K
Shares Held After
995,334
% of Holdings
1.6%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$45.01
Total Value
$126.02K
Shares Held After
10,503
% of Holdings
21.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,500
Price
$44.04
Total Value
$154.15K
Shares Held After
13,303
% of Holdings
20.8%
Showing 2851–2900 of 3367 transactions (page 58 of 68)